CIMCX
Price
$27.40
Change
+$0.08 (+0.29%)
Updated
Jun 2 closing price
Net Assets
146.54B
LGMNX
Price
$27.49
Change
+$0.04 (+0.15%)
Updated
Jun 2 closing price
Net Assets
2.83B
Interact to see
Advertisement

CIMCX vs LGMNX

Header iconCIMCX vs LGMNX Comparison
Open Charts CIMCX vs LGMNXBanner chart's image
CIMCX vs LGMNX Comparison Chart in %
View a ticker or compare two or three
VS
CIMCX vs. LGMNX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIMCX is a Buy and LGMNX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CIMCX has more cash in the bank: 147B vs. LGMNX (2.83B). CIMCX pays higher dividends than LGMNX: CIMCX (2.73) vs LGMNX (1.25). CIMCX was incepted earlier than LGMNX: CIMCX (24 years) vs LGMNX (9 years). CIMCX (1.35) is less costly to investors than LGMNX (0.83). CIMCX is a more actively managed with annual turnover of: 65.00 vs. LGMNX (35.00). CIMCX has a lower initial minimum investment than LGMNX: CIMCX (250) vs LGMNX (1000000). LGMNX annual gain was more profitable for investors over the last year : 10.74 vs. CIMCX (8.06). CIMCX return over 5 years is better than : 20.12 vs. LGMNX (-0.26).
CIMCXLGMNXCIMCX / LGMNX
Total Expense Ratio1.350.83163%
Annual Report Gross Expense Ratio1.350.83163%
Fund Existence24 years9 years-
Gain YTD5.6546.68585%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets147B2.83B5,193%
Annual Yield % from dividends2.731.25219%
Returns for 1 year8.0610.7475%
Returns for 3 years33.0729.19113%
Returns for 5 years20.12-0.26-7,650%
Returns for 10 years67.70N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JLCAX23.77N/A
N/A
JPMorgan US Large Cap Core Plus A
OINCX25.45N/A
N/A
JPMorgan Equity Income C
PHSKX37.47N/A
N/A
Virtus KAR Mid-Cap Growth A
MXNSX22.96N/A
N/A
Empower S&P SmallCap 600® Index L
RYCFX45.37N/A
N/A
Rydex Biotechnology C